UK Private Health Insurance Denied Cancer Treatment: How to Appeal

A cancer diagnosis is one of the most frightening experiences a person can face. Being told by your private health insurer that a recommended treatment will not be covered makes an already devastating situation worse. Yet cancer treatment denials are among the most frequently appealed — and frequently overturned — types of UK health insurance decisions.

If your insurer has denied a cancer treatment claim, here is what you need to know.

Common Reasons UK Insurers Deny Cancer Treatment Claims

Experimental or unproven treatment. Insurers frequently deny claims for treatments they classify as "experimental," "investigational," or "not proven to be clinically effective." This can include newer immunotherapy drugs, CAR-T therapies, or treatments used in clinical trials. The challenge is that what an insurer calls "experimental" may be standard-of-care according to your oncologist and the broader medical community.

Drug not listed on the approved formulary. Some PMI policies only cover cancer drugs from a specific approved list. If the drug your oncologist recommends is not on the insurer's formulary, the claim may be denied even if the drug is licensed, available, and NICE-appraised.

Treatment beyond policy limits. Cancer care can be long and intensive. PMI policies typically have monetary limits on cancer cover. Once reached, the insurer will stop paying, leaving the patient to fund further treatment privately or transition to NHS care.

Pre-existing condition argument. If your cancer or a related condition had any documented history before your policy start date — even a vague symptom — the insurer may attempt to deny on pre-existing condition grounds.

NHS Cancer Drugs Fund (CDF) already covers it. Insurers sometimes argue that because a drug is available through the NHS Cancer Drugs Fund, they are not required to pay for it privately. This argument is legally questionable — your PMI policy covers private treatment, and the availability of an NHS route does not excuse the insurer from its contractual obligation.

Step 1: Request Full Clinical Justification from Your Oncologist

Before filing any appeal, ask your oncologist for a comprehensive letter that:

• Confirms your diagnosis and staging
• Explains why the recommended treatment is clinically appropriate
• References NICE guidance, European oncology guidelines, or published clinical evidence supporting the treatment
• Directly addresses any "experimental" designation the insurer has used

This letter is the core of your appeal.

Step 2: Investigate the Policy's Cancer Cover

Review your policy document carefully. Pay particular attention to:

• The cancer cover section — what types of treatment and drugs are included
• Any exclusions for "experimental" or "unproven" treatments and how these terms are defined
• Monetary or benefit limits on cancer cover
• Pre-authorisation requirements for cancer treatment
• The IPID (Insurance Product Information Document) you received at sale

If the policy's description of cancer cover does not match how the insurer is applying it, that discrepancy is the basis of your appeal.

Step 3: File a Formal Complaint — With Urgency

Cancer treatment denials have an urgent time dimension. File your formal complaint immediately and explicitly state that the denial is time-sensitive due to the nature of the treatment. Request that the insurer fast-track its review.

Cite:

• The policy clause entitling you to cancer treatment
• Your oncologist's clinical justification
• The FCA Consumer Duty requirement for fair outcomes — denying a clinically indicated cancer treatment when the policy covers cancer care is difficult to defend under this standard
• Any NICE guidance or clinical body guidelines supporting the treatment

Step 4: Financial Ombudsman Service — Urgent Track

The FOS handles urgent cases and can fast-track complaints where there is a risk to health if the matter is not resolved quickly. When you contact the FOS, clearly explain that this involves ongoing cancer treatment and that delay has clinical consequences.

The FOS has upheld numerous cancer treatment disputes, particularly where insurers have applied "experimental treatment" exclusions to drugs that are NICE-approved or widely accepted in clinical practice.

File at financial-ombudsman.org.uk or call 0800 023 4567 and ask for urgent handling.

The Cancer Drugs Fund and Private Insurance

The NHS Cancer Drugs Fund provides access to certain cancer drugs in England that are not routinely available on the NHS. If your drug is available through the CDF, you may be able to receive it on the NHS while your insurance dispute is resolved — but this is a parallel option, not a reason your insurer can use to deny your private claim.

In Scotland, Wales, and Northern Ireland, equivalent cancer drug access schemes exist. Check with your NHS oncologist about your options.

Experimental Treatment Exclusions: How to Challenge Them

The "experimental treatment" exclusion is one of the most contested in cancer insurance disputes. To challenge it:

1. Check whether the drug or treatment is licensed (MHRA-licensed or EMA-licensed)
2. Check whether it has NICE approval or is on NICE guidance for your cancer type and stage
3. Ask your oncologist whether the treatment is standard-of-care in the UK or internationally
4. Review whether the policy's definition of "experimental" actually applies — if the treatment has a NICE technology appraisal, calling it experimental is very difficult to sustain

Your Rights When Cover Runs Out

If your cancer cover has reached its monetary limit, you are not without options:

• Speak to your oncologist about transitioning relevant treatment to the NHS
• Contact Macmillan Cancer Support or Cancer Research UK for guidance on accessing NHS treatment
• Investigate whether your treatment is available through the NHS CDF
• If the limit was reached faster than expected due to insurer miscalculation or delays in approval, include this in your FOS complaint

Fight Back With ClaimBack

Cancer treatment denials are urgent and high-stakes. ClaimBack helps you prepare a compelling, evidence-backed appeal that addresses the insurer's specific objections and asserts your rights under both your policy and FCA regulation.

Start your appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• UK Financial Ombudsman Service: Complete Guide